Ang2 and VEGF inhibitor combinations

Details for Australian Patent Application No. 2007210234 (hide)

Owner Amgen Inc.

Inventors Kendall, Richard; Kumar, Rakesh; Oliner, Jonathan

Agent Shelston IP

Pub. Number AU-B-2007210234

PCT Pub. Number WO2007/089445

Priority 60/762,493 27.01.06 US

Filing date 19 January 2007

Wipo publication date 9 August 2007

Acceptance publication date 29 July 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/00 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/089445 Priority application(s): WO2007/089445

29 July 2010 Application Accepted

  Published as AU-B-2007210234

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007210245-Masonry stain resistance agents

2007210230-Method and apparatus for automatic selection of alternative routing through congested areas using congestion prediction metrics